Loading ......
Haemophilus influenzae type b (Hib) is a Gram-negative coccobacillus responsible for a range of serious invasive diseases, especially in young children. These conditions can include meningitis, pneumonia, epiglottitis, and bacteremia. While the Hib vaccine has dramatically reduced the global incidence of these infections, measuring antibody levels is crucial for assessing vaccine efficacy, evaluating immune response in immunocompromised individuals, and for research purposes. The Human Haemophilus Influenza B (Hib) IgG ELISA Kit is a powerful and specific in vitro diagnostic tool designed for the quantitative detection of human IgG antibodies against Hib capsular polysaccharide.
Figure 1. Haemophilus influenzae type b (Hib).
Kit Components
Specifications
Assay Principle
Sample Collection & Preparation
Issue
Possible Cause
Applications
This is where the Human Haemophilus Influenzae B IgG ELISA Kit plays a pivotal role. Designed to quantify IgG antibodies specific to Hib in human biological samples, this kit provides a reliable, standardized method to assess immune status. IgG antibodies, which are produced by the immune system in response to infection or vaccination, persist for extended periods, making them ideal markers of long-term immunity. By measuring Hib-specific IgG levels, healthcare providers, researchers, and public health officials can evaluate vaccine efficacy, monitor population-level protection, identify individuals in need of booster doses, and support epidemiological surveillance. In essence, the Hib IgG ELISA Kit is not just a laboratory tool—it is a cornerstone of efforts to sustain the progress made against Hib and to extend that progress to underserved populations worldwide.

The analysis of the results from the Human Hib IgG ELISA is quantitative and requires the construction of a standard curve.

Standard Curve Generation
The x-axis represents the concentration of anti-Hib IgG, and the y-axis represents the absorbance.
A four-parameter logistic regression curve is the most common and accurate method for fitting the standard curve.

Calculating Sample Concentrations
For each unknown sample, use its measured absorbance value and the generated standard curve to determine the corresponding anti-Hib IgG concentration.
Multiply this interpolated concentration by the sample dilution factor (e.g., 1:100) to get the final concentration in the original undiluted sample.
Concentrations are typically reported in µg/mL or mIU/mL.

| Parameter | Details |
| Product name | Human Haemophilus Influenza B IgG ELISA Kit |
| Sample | Serum, plasma |
| Intended Use | Human Haemophilus Influenza B IgG ELISA is an enzyme immunoassay for determination of IgG antibodies against polyribosylribitol phosphate of Haemophilus influenzae type B in human serum and plasma. |
| Species Reactivity | Human |
| General Description | Haemophilus influenzae type B (HiB) is a very common cause of invasive critical infectious diseases in children up to the age of six. Following infection the symptoms of the disease include: Pericarditis, osteomyelitis, meningitis, encephalitis, pneumonia, sinusitis and otitis. In many cases the disease is lethal or leads to neurological damage, which cannot always be prevented by rapid antibiotic therapy. The underlying reason for the disease is very often a latent immunodeficiency with a specifically reduced humoral immune response to the polyribosylribitol phosphate (PRP) in the polysaccharide encapsulation of the bacterium. In children another reason is the immaturity of the immune system. Today often the term "immunocompromised patients" is used, comprising all acquired and innate specific and unspecific immunodeficiencies. |

Fast turnaround time
Most test kits can detect results within 2-3 hours, which is faster than virus culture and on par with RIDT. This allows clinicians to make clinical decisions in a timely manner (eg. start antiviral therapy).

High Specificity and Sensitivity
The wells are pre-coated with a highly purified Hib capsular polysaccharide antigen. This ensures that only the specific anti-Hib IgG antibodies from the sample will bind, minimizing the risk of false-positive results from cross-reactive antibodies.

Efficiency and Throughput
The 96-well microplate format allows for the simultaneous processing of a large number of samples, making it highly efficient for laboratories and research studies. A single plate can accommodate standards, controls, and many patient samples.
The Human Haemophilus Influenzae B IgG ELISA Kit is an essential tool for monitoring immunity to Hib, supporting vaccine development, and guiding public health strategies. By providing quantitative data on anti-Hib IgG levels, it helps ensure effective protection against a pathogen that once posed a major threat to global child health. For optimal results, users should follow strict protocol adherence, validate with controls, and interpret findings in conjunction with clinical and epidemiological context.
Loading ......